Abstract
Introduction
Goblet cell carcinoma (GCC) is an appendicular neoplasia representing less than 5% of all appendicular tumors, found in 0.3–0.9% of the appendectomies, 35–58% of all appendicular neoplasms, and less than 14% of malign appendix tumors. The most frequent clinical presentation is abdominal pain associated with a picture of acute appendicitis.
Materials and methods
We present 3 clinical cases of appendix GCC, 2 subjected to cytoreductory surgery plus intraperitoneal hyperthermic chemotherapy and a third, who is currently receiving neoadjuvant treatment with a good response to chemotherapy and who will be offered the same treatment as the first two patients. Given the unpredictable behavior of these tumors, the use of molecular markers could help us to predict their behavior and prognosis. In this context, the TP73 gene would make an interesting putative marker. ∆Np73 has been described as overexpressed in a great variety of tumor types including colon cancer and this up-regulation is associated with a poor prognosis. To evidence its role in this malignancy, we evaluate here the status of ∆Np73 in the primary tumor and normal counterpart tissues, in the metastatic implants and in healthy areas of the peritoneum from the appendicular GCC patients. In addition, we checked the expression levels of this p73 variant in the tumor and normal tissue of 26 patients with colon cancer.
Results
Remarkably, 2 patients showed significant ∆Np73 down-regulation in both the primary tumor and the implants. Case 1 presented a fourfold decrease of levels in the primary tumor and 20-fold decrease in the implants. Case 2 showed a seven- and fourfold down-regulation in the primary tumor and implants, respectively. However, Case 3 showed an up-regulation of 53- and threefold in the primary tumor and implants, respectively.
Conclusion
Goblet cell carcinoma of the appendix is very rate. It tends to seed throughout the peritoneum, making aggressive surgical cytoreduction and chemotherapy viable treatment options. Investigation into the molecular basis of these tumors may improve the diagnosis, prognosis and therapeutic decisions regarding these patients. ∆Np73 seems a good candidate for further analysis in longer series.
Similar content being viewed by others
References
Tang LH, Shia J, Soslow RA, Dhall D, Wong WD, O’Reilly E, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32(10):1429–43.
Reid MD, Basturk O, Shaib WL, Xue Y, Balci S, Choi HJ, et al. Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases. Mod Pathol. 2016;29(10):1243–53.
Madani A, Van der Bilt JDW, Consten ECJ, Menno R, et al. Perforation in appendiceal well-differentiated carcinoid and goblet cell tumors: impact on prognosis? A systematic review. Ann Surg Oncol. 2015;22:959–65.
Ibrahim U, Valecha G, Garcia G, Saqib A, Wrzolek M, Dhar M. adenocarcinoma ex-goblet cell carcinoidof the appendix: a case report and overview of the disease. J Gastrointest Cancer. 2017. https://doi.org/10.1007/s12029-017-9926-9.
Chetty R, Klimstra DS, Henson DE, Albores-Saavedra J. Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix. Am J Surg Pathol. 2010;34(8):1163–7.
Holt N, Grønbæk H. Goblet cell carcinoids of the appendix. Sci World J. 2013. https://doi.org/10.1155/2013/543696.
Subbuswamy SG, Gibbs NM, Ross CF, Morson BC. Goblet cell carcinoid of the appendix. Cancer. 1974;34(2):338–44.
Reid MD, Basturk O, Shaib WL, Xue Y, Balci S, Choi HJ, et al. Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma)is a morphologically distinct entity with highlyaggressive behavior and frequent associationwith peritoneal/intra-abdominal dissemination. Mod Pathol. 2016;29:1243–53.
Bucher P, Gervaz P, Ris F, Oulhaci W, Egger JF, Morel P. Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg. 2005;29:1436e9.
Kanthan R, Saxena A, Kanthan SC. Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med. 2001;125(3):386–90.
Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, et al. Goblet cell appendiceal tumors. Management dilemmas and long-term outcomes. Surg Oncol. 2015;24:47e53.
Soldevilla B, Rodríguez M, San Millán C, García V, Fernández-Periañez R, Gil-Calderón B, et al. Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival. Hum Mol Genet. 2014;23(2):467–78.
Soldevilla B, Millán CS, Bonilla F, Domínguez G. The TP73 complex network: ready for clinical translation in cancer? Genes Chromosomes Cancer. 2013;52(11):989–1006.
Soldevilla B, Díaz R, Silva J, Campos-Martín Y, Muñoz C, García V, et al. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients. Clin Cancer Res. 2011;17(18):6029–39.
Wang HL, Dhall D. Goblet or signet ring cells that is the question. Adv Anat Pathol. 2009;16(4):247–54.
Alsaad KO, Serra S, Chetty R. Combined goblet cell carcinoid and mucinous cystadenoma of the vermiform appendix. World J Gastroenterol. 2009;15(27):3431–3.
Ramnani DM, Wistuba II, Behrens C, Gazdar AF, Sobin LH, Albores-Saavedra J, et al. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer. 1999;86:14–21.
Hristov AC, Young RH, Vang R, Yemelyanova AV, Seidman JD, Ronnett BMO. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007;31(10):1502–11.
Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A. Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med. 2015;139(6):78–90.
Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, et al. Goblet cell appendiceal tumors–management dilemmas and long-term outcomes. Surg Oncol. 2015.
Leea KS, Tangb LH, Shiab J, Patyc PB, Weiserc MR, Guillemc JG, et al. Goblet cell carcinoid neoplasm of the appendix: clinical and CT features. Eur J Radiol. 2013;82:85–9.
Shaib WL, Martin LK, Choi M, Chen Z, Krishna K, Kim S, et al. Hyperthermic intraperitoneal chemotherapy following cytoreductivesurgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a pooled analysis from three tertiary care centers. Oncologist. 2015;20:907–14.
Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination. Clin Colon Rectal Surg. 2005;18(3):204–14.
Cashin P, Nygren P, Hellman P, Granberg D, Andr easson H, Mahteme H. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer. 2011;10:108e12.
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19:1390–408.
Sanz CM, Sugarbaker PH. Adenocarcinoid of appendiceal origin causing peritoneal carcinomatosis. Reg Cancer Treat. 1994;7:211–6.
Mahteme H, Sugarbaker PH. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg. 2004;91:1168–70.
Pham TH, Wolf B, Abraham SC, Drelichman E. Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol. 2017;13(3):370–6.
Gagné F, Fortin P, Dufour V, Delage C. Tumors of the appendix associating histologic features of carcinoid and adenocarcinoma. Ann d’Anat Pathol. 1969;14(4):393–406.
Sobin Leslie H, Albores-Saavedra Jorge. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med. 2001;125(3):386–90.
Domínguez G, García JM, Peña C, Silva J, García V, Martínez L, et al. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1. J Clin Oncol. 2006;24(5):805–15.
Acknowledgements
We acknowledge ISCIII, FIS, FEDER and Cátedra UAM-ROCHE de Medicina de Innovación for funding our current research through the PI18/00473 and CIBERONIC. Gemma Domínguez and Nuria Rodriguez have received research grants from Roche Farma SA.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Nuria Rodríguez and Gemma Domínguez are funded by Roche Farma through “Cátedra de Medicina de Innovación UAM-ROCHE”, for conducting teaching and research programs in the context of the Universidad Autónoma de Madrid. The other authors declare no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Prieto-Nieto, M.I., Pastor, D., Rodríguez-Cobos, J. et al. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells). Clin Transl Oncol 21, 1432–1439 (2019). https://doi.org/10.1007/s12094-019-02091-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-019-02091-1